SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001328143-20-000004
Filing Date
2020-01-08
Accepted
2020-01-08 09:16:44
Documents
3
Period of Report
2020-01-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K adms8-kq4revenueandcompany.htm 8-K 26747
2 EXHIBIT 99.1 adms991q42019revenueandcom.htm EX-99.1 16653
3 adamaslogoa02.jpg GRAPHIC 11911
  Complete submission text file 0001328143-20-000004.txt   61317
Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36399 | Film No.: 20514614
SIC: 2834 Pharmaceutical Preparations